Coverage
-
August 31, 2020
Vivera Pharmaceuticals Inc. dismissed its federal defamation lawsuit Friday against Gannett, several executives and four USA Today reporters alleging it has suffered $500 million in damages because of a story that criticized its COVID-19 antibody tests, saying it has plans to refile its claims in state court.
1 other articles on this case.
View all »